Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developments in Intralesional Therapy for Metastatic Melanoma
Sarah Sloot, Omar M. Rashid, Amod A. Sarnaik, et al.
Cancer Control (2016) Vol. 23, Iss. 1, pp. 12-20
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Monodisperse and Uniform Mesoporous Silicate Nanosensitizers Achieve Low‐Dose X‐Ray‐Induced Deep‐Penetrating Photodynamic Therapy
Wenjing Sun, Tianhang Shi, Li Luo, et al.
Advanced Materials (2019) Vol. 31, Iss. 16
Closed Access | Times Cited: 128
An SVM Framework for Malignant Melanoma Detection Based on Optimized HOG Features
Samy Bakheet
Computation (2017) Vol. 5, Iss. 1, pp. 4-4
Open Access | Times Cited: 100
BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases
Alok Kumar Singh, Mihai G. Netea, William R. Bishai
Journal of Clinical Investigation (2021) Vol. 131, Iss. 11
Open Access | Times Cited: 65
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Hillard M. Lazarus, Carolyn E. Ragsdale, Robert Peter Gale, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Current status of intralesional agents in treatment of malignant melanoma
Misam Zawit, Umang Swami, Hassan Awada, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 12, pp. 1038-1038
Open Access | Times Cited: 37
Transduction Methods for Cytosolic Delivery of Proteins and Bioconjugates into Living Cells
Manuela Chiper, Karen Niederreither, Guy Zuber
Advanced Healthcare Materials (2017) Vol. 7, Iss. 6
Open Access | Times Cited: 43
Non-Melanoma Skin Cancer: news from microbiota research
Diletta Francesca Squarzanti, Elisa Zavattaro, Stefania Pizzimenti, et al.
Critical Reviews in Microbiology (2020) Vol. 46, Iss. 4, pp. 433-449
Closed Access | Times Cited: 33
Localized delivery of immunotherapy via implantable scaffolds for breast cancer treatment
A. Hope, Samantha J. Wade, Morteza Aghmesheh, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 399-413
Closed Access | Times Cited: 29
Comparative real-world outcomes of stage III melanoma patients treated with talimogene laherparepvec or interleukin 2
Markus Reitmajer, Lena Nanz, Nina Müller, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Principles of Immunotherapy in Melanoma
Adedayo A. Onitilo, Jaimie A. Wittig
Surgical Clinics of North America (2019) Vol. 100, Iss. 1, pp. 161-173
Closed Access | Times Cited: 34
Mycobacterium bovis BCG in metastatic melanoma therapy
Martha Ruiz, Camila Bonnemann Bender, Thaís Larré Oliveira, et al.
Applied Microbiology and Biotechnology (2019) Vol. 103, Iss. 19, pp. 7903-7916
Open Access | Times Cited: 31
Efficacy of Bacillus Calmette-Guérin in Cancer Prevention and Its Putative Mechanisms
Sakshi Gupta, S Satyavir Yadav, Pawan Kumar
Journal of Cancer Prevention (2024) Vol. 29, Iss. 1, pp. 6-15
Open Access | Times Cited: 3
Electrochemotherapy with anti-PD-1 treatment induced durable complete response in heavily pretreated metastatic melanoma patient
Burçak Karaca, G. Yayla, Mehmet Remzi Erdem, et al.
Anti-Cancer Drugs (2017) Vol. 29, Iss. 2, pp. 190-196
Closed Access | Times Cited: 24
Intralesional therapy as a treatment for locoregionally metastatic melanoma
John T. Miura, Jonathan S. Zager
Expert Review of Anticancer Therapy (2018) Vol. 18, Iss. 4, pp. 399-408
Closed Access | Times Cited: 21
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0
Joseph Markowitz, Michael J. Shamblott, Andrew S. Brohl, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 8, pp. 1139-1143
Open Access | Times Cited: 2
Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
Marlana Orloff
Oncolytic Virotherapy (2016) Vol. Volume 5, pp. 91-98
Open Access | Times Cited: 17
Molecular distribution in intradermal injection for transfer and delivery of therapeutics
Emran O. Lallow, Kishankumar J. Busha, Sarah H. Park, et al.
Frontiers in Drug Delivery (2023) Vol. 3
Open Access | Times Cited: 5
Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?
Luke D. Rothermel, Jonathan S. Zager
Expert Opinion on Biological Therapy (2018) Vol. 18, Iss. 12, pp. 1199-1207
Closed Access | Times Cited: 16
Bacillus Calmette‐Guerin, polysaccharide nucleic acid in the treatment of cutaneous and oral lichen planus
Mohamad Mahmoud Nasr, Howyda M. Ebrahim, Fathia M. Khattab, et al.
Dermatologic Therapy (2018) Vol. 31, Iss. 3
Open Access | Times Cited: 13
Intralesional interleukin‐2: A novel option to maximize response to systemic immune checkpoint therapy in loco‐regional metastatic melanoma
Ewan A. Langan, Christiane Kümpers, Victoria Graetz, et al.
Dermatologic Therapy (2019) Vol. 32, Iss. 3
Open Access | Times Cited: 13
Clinical and molecular overview of immunotherapeutic approaches for malignant skin melanoma: Past, present and future
Raphaelly Venzel, Maria Clara Paulino Campos, Larissa Pessoa de Oliveira, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103988-103988
Closed Access | Times Cited: 4
MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience
Aymeric Rauch, Roberto Luigi Cazzato, Julien Garnon, et al.
CardioVascular and Interventional Radiology (2017) Vol. 40, Iss. 8, pp. 1285-1289
Closed Access | Times Cited: 11
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient
Dejan Vidovic, Gordon A. Simms, Sylvia Pasternak, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 10
Pharmacokinetic drug evaluation of talimogene laherparepvec for the treatment of advanced melanoma
Erin E. Burke, Jonathan S. Zager
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 14, Iss. 4, pp. 469-473
Closed Access | Times Cited: 9
Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: The Knowns and the Unknowns
Naomi Aronson, Kendall Billick
Clinical Infectious Diseases (2023) Vol. 77, Iss. 4, pp. 583-588
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top